Infarct related culprit Versus Non- culprit vessel revascularization

Infarct related culprit Vs. non- culprit vessel revascularization

A 38 year old male smoker and hypertensive presented with severe retrosternal chest pain of 3 hours duration. On examination he was hypertensive with BP = 80/50 sinus bradycardia with HR 40bpm, right sided S3 and chest clear. He recently underwent primary PCI to LAD a month ago, coronary angiogram at that time revealed LAD 90% stenosis, LCX mid 50% stenosis, RCA proximal 60-70% stenosis and Right PDA has 80% osteal stenosis.

ECG on current presentation showed sinus bradycardia and ST depressions more than 2mm in inferior leads. Please give answer of following questions based on guidelines

a) Is TPM indicated, if yes then give justification

b) Name the culprit vessel

c) Do you think revascularization of non-culprit vessel at time of primary PCI would have prevented current cardiac event

d) Name the trials which have studied such scenarios

Answers:

a. Yes, Symptomatic bradycardia
b. RCA/PDA
c. Yes
d. DANAMI, PRAGUE, CULPRIT and PRAMI Trail (Infarct related culprit Vs. non- culprit vessel revascularization)

Reference:

1. Chapter 22, page 390 – Bradyarrythmias - Manual of Cardiovascular Medicine Fourth Edition - Brian P. Griffin MD FACC

2. Engstrom T, Kelbaek H, Helqvist S, et al. Complete revascularization versus treatment of the culprit lesion only in patients with ST segment elevation myocardial infarction and multi vessel disease (DANAMI 3- PRIMULTI) an open – label randomized controlled trial. Lancet 2015;386:665-71.10.1016/S0140-6736(15)60648-1 [Pubmed]

Comments

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Dr. Usman's Cardiology Notes

Search This Blog